| Literature DB >> 16002075 |
Daiji Kawanami1, Koji Maemura, Norihiko Takeda, Tomohiro Harada, Takefumi Nojiri, Tetsuya Saito, Ichiro Manabe, Yasushi Imai, Ryozo Nagai.
Abstract
Recent studies have shown that C-reactive protein (CRP) is not just a predictor of cardiovascular events but also acts directly as a proinflammatory stimulus in vascular cells. In this report, we studied the molecular mechanisms underlying vascular cellular adhesion molecule-1 (VCAM-1) induction by CRP. CRP-induced VCAM-1 mRNA expression and this induction was inhibited by protein kinase C (PKC) inhibitors, p38 mitogen-activated protein kinase (MAPK) inhibitor, and tyrosine kinase inhibitors. In addition, parthenolide, a nuclear factor kappaB (NF-kappaB) inhibitor, abolished VCAM-1 induction. Moreover, CRP increased VCAM-1 promoter activity, indicating that CRP induces VCAM-1 mRNA expression at the transcriptional level. Mutation of NF-kappaB-binding sites resulted in a loss of induction. Finally, an electrophoretic mobility shift assay confirmed binding of the p65 subunit of NF-kappaB to kappaB-binding sites. Taken together, our findings suggest that VCAM-1 induction by CRP is mediated by PKC, p38MAPK, tyrosine kinase and the NF-kappaB-dependent signaling pathways in vascular endothelial cells.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16002075 DOI: 10.1016/j.atherosclerosis.2005.01.057
Source DB: PubMed Journal: Atherosclerosis ISSN: 0021-9150 Impact factor: 5.162